Keros Therapeutics (KROS) Cash from Investing Activities (QoQ) (2019 - 2025)
Keros Therapeutics (KROS) Cash from Investing Activities (QoQ) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Keros Therapeutics | 217.61 Mn | -40.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.52% |
| Sep 30, 2025 | 81.67% |
| Jun 30, 2025 | -27.43% |
| Mar 31, 2025 | -95.50% |
| Dec 31, 2024 | 25.13% |
| Sep 30, 2024 | -24.52% |
| Jun 30, 2024 | 67.23% |
| Mar 31, 2024 | -74.86% |
| Dec 31, 2023 | 1.64% |
| Sep 30, 2023 | -76.85% |
| Jun 30, 2023 | 70.72% |
| Mar 31, 2023 | -202.56% |
| Dec 31, 2022 | -99.43% |
| Sep 30, 2022 | 68.96% |
| Jun 30, 2022 | -285.71% |
| Mar 31, 2022 | 7.55% |
| Dec 31, 2021 | -9.66% |
| Sep 30, 2021 | 71.57% |
| Jun 30, 2021 | -142.86% |
| Mar 31, 2021 | -250.00% |